doxazosin and thyroxine

doxazosin has been researched along with thyroxine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Abu-Abeid, S; Aizpuru, A; Arriaga, S; Baranska, M; Barba de la Rosa, AP; Bunce, M; Carothers, MA; Casas-Flores, S; Costantino, M; Cruickshank, JK; Czamara, K; Drzayich Antol, D; Eldar, SM; Esquivel-González, S; Faconti, L; Gamble, DA; Gao, D; Gómez-Hernández, N; Govoni, V; Gu, H; Guo, J; Hanaoka, H; Haruyama, H; Hazzan, D; Hopson, S; Hua, H; Iso, T; Ji, M; Jiang, B; Kaczor, A; Karnas, E; Khoury, R; Kong, F; Kou, Y; Kurabayashi, M; Lahat, G; Li, X; Liang, X; Lin, J; Liu, S; Liu, X; Majka, Z; Matsui, H; Matsui, M; Meves, JM; Michael, T; Mills, CE; Morant, S; Nachmani, I; Negishi, K; Nevo, N; Niu, L; Palomo-Briones, R; Pan, W; Parikh, A; Peterson, ME; Putri, M; Renda, A; Rishniw, M; Shao, CH; Stein, A; Stemkowski, S; Sun, H; Sun, X; Sunaga, H; Syamsunarno, MRAA; Tanaka, R; Tang, R; Tu, J; Umbarawan, Y; Waldman Casebeer, A; Wang, W; Wang, X; Wang, XY; Wang, Y; Webb, AJ; Wojcik, T; Wu, YJ; Xia, X; Xie, D; Xue, M; Yamaguchi, A; Yang, Y; Ying, HM; Yokoyama, T; Zhan, LX; Zhang, B; Zhang, L; Zhang, Q; Zhang, Y; Zhong, Y; Zhou, F; Zuba-Surma, EK; Zuo, D	1

Reviews

1 review(s) available for doxazosin and thyroxine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for doxazosin and thyroxine

Article	Year
Journal of patient-reported outcomes, 2018, Volume: 2 Topics: Adult; Aged; Animals; Astrocytes; Bariatric Surgery; Beta vulgaris; Bioreactors; Biotechnology; Blood Pressure; Body Mass Index; Cat Diseases; Cats; CD36 Antigens; Cell Cycle; Cell Line; Chitinases; Cohort Studies; Comorbidity; Cytokines; Diabetes Mellitus, Type 2; Double-Blind Method; Doxazosin; Echocardiography; Encephalomyelitis, Autoimmune, Experimental; Endothelial Cells; Fasting; Female; Fruit and Vegetable Juices; Gastric Bypass; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Heart; Heart Failure; Homeostasis; Humans; Hypertension; Hypothyroidism; Inflammation; Interleukin-17; Laparoscopy; Length of Stay; Male; Methanol; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbiota; MicroRNAs; Middle Aged; Molecular Imaging; Nitrates; Nutrients; Obesity, Morbid; Pancreatic Neoplasms; Physical Conditioning, Animal; Physical Endurance; Pichia; Placebos; Postoperative Complications; Postoperative Period; Prospective Studies; Pulse Wave Analysis; Radionuclide Imaging; Reoperation; Retrospective Studies; RNA, Messenger; Sequence Analysis, RNA; Signal Transduction; Spectrum Analysis, Raman; Spironolactone; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Thyroid Gland; Thyrotropin; Thyroxine; Treatment Outcome; Ultrasonography; Vascular Stiffness; Weight Loss	2018

Article

Year

Journal of patient-reported outcomes, 2018, Volume: 2

Topics: Adult; Aged; Animals; Astrocytes; Bariatric Surgery; Beta vulgaris; Bioreactors; Biotechnology; Blood Pressure; Body Mass Index; Cat Diseases; Cats; CD36 Antigens; Cell Cycle; Cell Line; Chitinases; Cohort Studies; Comorbidity; Cytokines; Diabetes Mellitus, Type 2; Double-Blind Method; Doxazosin; Echocardiography; Encephalomyelitis, Autoimmune, Experimental; Endothelial Cells; Fasting; Female; Fruit and Vegetable Juices; Gastric Bypass; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Heart; Heart Failure; Homeostasis; Humans; Hypertension; Hypothyroidism; Inflammation; Interleukin-17; Laparoscopy; Length of Stay; Male; Methanol; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbiota; MicroRNAs; Middle Aged; Molecular Imaging; Nitrates; Nutrients; Obesity, Morbid; Pancreatic Neoplasms; Physical Conditioning, Animal; Physical Endurance; Pichia; Placebos; Postoperative Complications; Postoperative Period; Prospective Studies; Pulse Wave Analysis; Radionuclide Imaging; Reoperation; Retrospective Studies; RNA, Messenger; Sequence Analysis, RNA; Signal Transduction; Spectrum Analysis, Raman; Spironolactone; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Thyroid Gland; Thyrotropin; Thyroxine; Treatment Outcome; Ultrasonography; Vascular Stiffness; Weight Loss

2018

Other Studies

2 other study(ies) available for doxazosin and thyroxine

Article	Year
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012

Article

Year

Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.

Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008

Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.

Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012